Aarti Drugs Ltd.

Financial

	Aarti Drugs	Neuland Laboratories	Dishman Carbogen Amc
Operational Metrics
API Sector
APIs Production Capacity	45937.0 MTPA	n/a	n/a
Pharmaceutical Sector
R&D as a % of Total Sales	0.79 %	2.53 %	2.89 %
Financials
5 yr Average ROE	20.52 %	7.78 %	0.72 %
5yr average Equity Multiplier	2.24	1.65	1.49
5yr Average Asset Turnover Ratio	1.14	0.67	0.25
5yr Avg Net Profit Margin	8.19 %	6.73 %	1.79 %
Price to Book	3.82	7.65	0.48
P/E	28.58	32.69	0.0
5yr Avg Cash Conversion Cycle	83.04 Days	64.68 Days	42.6 Days
Inventory Days	64.18 Days	94.42 Days	101.13 Days
Days Receivable	108.5 Days	91.33 Days	80.42 Days
Days Payable	92.79 Days	114.5 Days	166.8 Days
5yr Average Interest Coverage Ratio	8.87	7.45	2.31
5yr Avg ROCE	23.42 %	11.07 %	2.38 %
5yr Avg Operating Profit Margin	14.88 %	15.88 %	20.95 %
5 yr average Debt to Equity	0.58	0.26	0.23
5yr CAGR Net Profit	13.13 %	58.32 %	n/a
5yr Average Return on Assets	9.44 %	4.76 %	0.54 %
Shareholdings
Promoter Holding	57.13 %	32.74 %	59.32 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-3.07 %	-3.48 %	0.0
Change in Mutual Fund Holding (3 Yrs)	3.49 %	3.01 %	-6.64 %

Business

	Aarti Drugs	Neuland Laboratories	Dishman Carbogen Amc
Product Wise Break-Up	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 81.0 Formulations 11.0 Speciality Chemical Intermediates 5.0 Intermediates 3.0 Generic Drug Substances(GDS) 0 Custom Manufacturing Solutions(CMS) 0 Cholesterol & Vit D Analogues 0 Quats & Generics 0 NCE APIs & Intermediates 0 Marketable Molecules 0 0	Product Wise Break-Up Formulations 0 Intermediates 0 Formulations 47.0 Active Pharmaceutical Ingredient (API) 0 0 NCE APIs & Intermediates 0 Quats & Generics 0 Speciality Chemical Intermediates 0 Marketable Molecules 0 Cholesterol & Vit D Analogues 0 Custom Manufacturing Solutions(CMS) 46.0 Others 7.0	Product Wise Break-Up Formulations 0 Intermediates 0 Generic Drug Substances(GDS) 0 Active Pharmaceutical Ingredient (API) 0 Contract Research & Contract Manufacturing (CRAMS) 68.6 API 13.0 Quats & Generics 4.5 Speciality Chemical Intermediates 0 Marketable Molecules 0 Cholesterol & Vit D Analogues 13.9 Custom Manufacturing Solutions(CMS) 0
Location Wise Break-Up	Location Wise Break-Up Asia Pacific 57.0 Europe 14.0 Africa 11.0 Latin America 10.0 North America 8.0 India 0 Rest of the World 0 USA 0	Location Wise Break-Up India 25.14 Asia Pacific 0 Latin America 0 Africa 0 North America 0 Rest of the World 12.48 Europe 30.97 USA 31.41	Location Wise Break-Up India 1.71 Asia Pacific 0 Latin America 0 Africa 0 North America 0 Rest of the World 98.29 Europe 0 USA 0
Therapeutic Area Break-Up	Therapeutic Area Break-Up Antibiotics 45.0 Anti-protozoals 17.0 Anti - Diabetes 15.0 Anti-inflamatory 11.0 Anti-fungal 9.0 Cardioprotectant 0 Speciality 0 Anticonvulsant 0 Antidepressant 0 Antibacterial 0 Non-APIs / Intermediates 0 Pain / Nerves 0 Hormone / Metabolism 0 Blood / Immunology 0 Antibiotic 0 Eyes 0 ADC-Warhead / ADC 0 Cancer 0 Others 3.0	Therapeutic Area Break-Up Anti-bacterial 19.72 Antibiotics 0 Anti-protozoals 0 Eyes 0 Anti-inflamatory 0 Non-APIs / Intermediates 0 ADC-Warhead / ADC 0 Anti - Diabetes 0 Pain / Nerves 0 Anti-fungal 0 Antibiotic 0 Blood / Immunology 0 Antidepressant 11.8 Cancer 0 Speciality 0 Anticonvulsant 10.46 Hormone / Metabolism 0 Cardioprotectant 0 Others 58.02	Therapeutic Area Break-Up Antibacterial 0 Antibiotics 0 Anti-protozoals 0 Ophthalmology 17.82 Anti-inflamatory 0 Non-APIs / Intermediates 31.68 ADC-Warhead / ADC 3.96 Anti - Diabetes 0 Pain Management 3.96 Anti-fungal 0 Antibiotics 3.96 Blood Related 3.96 Antidepressant 0 Oncology 20.79 Speciality 0 Anticonvulsant 0 Hormones 13.86 Cardioprotectant 0 Others 0.01

Aarti Drugs Ltd.

SIGN UP FOR FREE